Home Medicine Novel pathogenic variant of DICER1 in an adolescent with multinodular goiter, ovarian Sertoli–Leydig cell tumor and pineal parenchymal tumor of intermediate differentiation
Article
Licensed
Unlicensed Requires Authentication

Novel pathogenic variant of DICER1 in an adolescent with multinodular goiter, ovarian Sertoli–Leydig cell tumor and pineal parenchymal tumor of intermediate differentiation

  • Aleida Rivera-Hernández , Mónica Madrigal-González , Luz Mejía-Carmona , Isis Martínez-López , María Guadalupe Pérez-Hernández , Joaquín Bernal-Manjarrez , Sergio Luna-Vidal , Sarahí Reta-Guerrero , Marco Antonio Rodríguez-Florido and Lourdes Balcázar-Hernández ORCID logo EMAIL logo
Published/Copyright: June 13, 2023

Abstract

Objectives

To present a case of a new pathogenic variant of DICER1.

Case presentation

13-year-old female with non-toxic multinodular goiter and ovarian Sertoli–Leydig cell tumor, in whom a pineal parenchymal tumor of intermediate differentiation was diagnosed. Next-generation sequencing revealed a new germline mutation in the DICER1 gene (exon 16, c2488del [pGlu830Serfs*2] in heterozygosis), establishing the diagnosis of DICER1 syndrome.

Conclusions

Mutations in the DICER1 gene cause genetic predisposition to a wide spectrum of benign or malignant tumors from childhood to adulthood.


Corresponding author: Lourdes Balcázar-Hernández, Master of Science, Endocrinology Department, Hospital de Especialidades, UMAE CMN Siglo XXI, IMSS, Avenida Cuauhtémoc N. 330 Colonia Doctores. C.P. 06720, Mexico City, Mexico, Phone: +52 (55) 5627 6900, Ext. 21551, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no competing of interest.

  4. Informed consent: Informed consent was obtained from the patient’s parents.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. de Kock, L, Wu, MK, Foulkes, WD. Ten years of DICER1 mutations: provenance, distribution, and associated phenotypes. Hum Mutat 2019;40:1939–53. https://doi.org/10.1002/humu.23877.Search in Google Scholar PubMed

2. Schultze-Florey, RE, Graf, N, Vorwerk, P, Koscielniak, E, Schneider, DT, Kratz, CP. DICER1 syndrome: a new cancer syndrome. Klin Pädiatr 2013;225:177–8. https://doi.org/10.1055/s-0033-1337976.Search in Google Scholar PubMed

3. González, IA, Stewart, DR, Schultz, KAP, Field, AP, Hill, DA, Dehner, LP. DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma. Mod Pathol 2022;35:4–22. https://doi.org/10.1038/s41379-021-00905-8.Search in Google Scholar PubMed PubMed Central

4. National Library of Medicine. National center for biotechnology information. https://www.ncbi.nlm.nih.gov/clinvar/?term=dicer1%5Bgene%5D [Accessed 29 Mar 2023].Search in Google Scholar

5. de Kock, L, Priest, JR, Foulkes, WD, Alexandrescu, S. An update on the central nervous system manifestations of DICER1 syndrome. Acta Neuropathol 2020;139:689–701. https://doi.org/10.1007/s00401-019-01997-y.Search in Google Scholar PubMed

6. Toll, S, Gupte, A, Sood, S, Kupsky, W, Altinok, D, Miller, S, et al.. Rare-53. Pineal parenchymal tumor of intermediate differentiation (PPTID) and DICER1 syndrome: a case report. Neuro Oncol 2020;22:iii453–4. https://doi.org/10.1093/neuonc/noaa222.763.Search in Google Scholar

7. Gupte, A, Sood, S, Kupsky, WJ, Altinok, D, Miller, S, Roy, S, et al.. Pineal parenchymal tumor of intermediate differentiation and DICER1 syndrome: a case report. J Pediatr Hematol Oncol 2023;45:e406–9. https://doi.org/10.1097/MPH.0000000000002518.Search in Google Scholar PubMed

8. Nosé, V. DICER1 gene alterations in thyroid diseases. Cancer Cytopathol 2020;128:688–9. https://doi.org/10.1002/cncy.22327.Search in Google Scholar PubMed

Received: 2023-04-06
Accepted: 2023-06-01
Published Online: 2023-06-13
Published in Print: 2023-08-28

© 2023 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. Metabolic risk factors in prepubertal and pubertal patients with overweight and obesity
  4. Blood pressure in girls with central precocious puberty receiving GnRH analogue therapy
  5. Norethindrone dosing for adequate menstrual suppression in adolescents
  6. Apparent diffusion coefficient (ADC) measurements and morphometric evaluation of the cranium in age-matched children with central precocious puberty
  7. Characteristics of vitamin D deficiency hypocalcemia inpatient admissions at a single tertiary center
  8. Early pregnancy exposure of maternal triglyceride levels and its effects on birth weight
  9. Evaluation of the clinical, biochemical, and genetic presentation of neonatal and adult-onset 5,10-methylene tetrahydrofolate reductase (MTHFR) deficiency in patients from Pakistan
  10. Congenital hypothyroidism in Bogotá, Colombia: a current description (2015–2021)
  11. Case Reports
  12. Case report: mitochondrial diabetes mellitus in a Chinese family due to m.3243A>G
  13. Novel pathogenic variant of DICER1 in an adolescent with multinodular goiter, ovarian Sertoli–Leydig cell tumor and pineal parenchymal tumor of intermediate differentiation
  14. Fibroblast growth factor 23 levels in cord and peripheral blood during early neonatal period as possible predictors of affected offspring of X-linked hypophosphatemic rickets: report of three female cases from two pedigrees
  15. A rare cause of hyperphenylalaninemia: four cases from a single family with DNAJC12 deficiency
  16. The benefit of rhGH therapy in a Chinese child with 12q14 microdeletion syndrome: a case report
  17. Adjustment of octreotide dose given via insulin pump based on continuous glucose monitoring (CGM) in a child with congenital hyperinsulinism
Downloaded on 16.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2023-0149/html?lang=en
Scroll to top button